These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10094925)

  • 21. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL.
    Gulec SA; Drouant GJ; Fuselier J; Anthony CT; Heneghan J; DelCarpio JB; Coy DH; Murphy WA; Woltering EA
    J Surg Res; 2001 May; 97(2):131-7. PubMed ID: 11341788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
    J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.
    Zacchigna S; Zentilin L; Morini M; Dell'Eva R; Noonan DM; Albini A; Giacca M
    Cancer Gene Ther; 2004 Jan; 11(1):73-80. PubMed ID: 14681728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
    Thompson EW; Nakamura S; Shima TB; Melchiori A; Martin GR; Salahuddin SZ; Gallo RC; Albini A
    Cancer Res; 1991 May; 51(10):2670-6. PubMed ID: 2021945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
    Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
    J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression.
    Larghero P; Venè R; Minghelli S; Travaini G; Morini M; Ferrari N; Pfeffer U; Noonan DM; Albini A; Benelli R
    Carcinogenesis; 2007 May; 28(5):1008-20. PubMed ID: 17127716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis.
    Cai T; Fassina G; Morini M; Aluigi MG; Masiello L; Fontanini G; D'Agostini F; De Flora S; Noonan DM; Albini A
    Lab Invest; 1999 Sep; 79(9):1151-9. PubMed ID: 10496534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
    Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
    Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
    Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
    Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
    J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.
    Lane BR; Liu J; Bock PJ; Schols D; Coffey MJ; Strieter RM; Polverini PJ; Markovitz DM
    J Virol; 2002 Nov; 76(22):11570-83. PubMed ID: 12388718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
    Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG
    Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.